NCT06837779

Brief Summary

The goal of this clinical trial is to learn if the application of fluoride works to treat patients suffering from dentin hypersensitivity. It will also learn about the safety of using fluoride iontophoresis with Acidulated phosphate fluoride gel. The main questions it aims to answer are: Does the remineralizing agent have the ability to decrease dentin sensitivity? Researchers will compare Fluoride Iontophoresis with Acidulated Phosphate Fluoride gel , Casein phosphopeptides-Amorphus calcium phosphate (CPP-ACP), nano-hydroxyapptite (NHAP) and -active glass in decreasing dentin hypersensitivity . Participants will:

  • Application of remineralizing agent every 3 months
  • Visit the dental clinic once every 3 months for checkups and tests

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2024

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2024

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

November 29, 2024

Completed
3 months until next milestone

First Posted

Study publicly available on registry

February 20, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

February 20, 2025

Status Verified

February 1, 2025

Enrollment Period

1.1 years

First QC Date

November 29, 2024

Last Update Submit

February 19, 2025

Conditions

Keywords

hypersinsitivityflouride iontophoresis

Outcome Measures

Primary Outcomes (1)

  • Visual Analogue Scale

    Measurement of sensitivity was performed after each stimulus by a Visual Analogue Scale, which consists of a 10-cm long line; the minimum value is 0 and the maximum value is 10, whether the higher scores mean worse and the lower score means better outcome. The patient's pain limits can suffer through an external stimulus; at 0, one end represents absence of discomfort, and the other represents severe discomfort caused by certain stimuli. Each time the patient is subjected to a stimulus, he or she is requested to point at the interval from 0 to 10, a number to correspond to the pain felt. The convenience of this type of scale is to allow demonstration of the pain intensity with absolute numbers or as a percentage of a maximum value

    12 months

Study Arms (2)

Fluoride Iontophoresis with Acidulated Phosphate Fluoride gel

EXPERIMENTAL

assessmen of iontophoresis effect on flouride ions flush to remineralization of demineralized enamel .The treatment will be assessed and recorded using VAS score immediately after the intervention, 3 months, 6 months and one year later.

Drug: Fluoride Iontophoresis with Acidulated Phosphate Fluoride

remineralizing agents

ACTIVE COMPARATOR

All remineralizing agents (Casein phosphopeptides -Amorphus Calcium Phosphate, Nano-hydroxyapatite, and Bioactive glass).

Drug: Remineralization with sodium fluoride varnish

Interventions

Application of fluoride gel and activated with Iontophoresis electrical pole

Fluoride Iontophoresis with Acidulated Phosphate Fluoride gel

CASIN PHOSPHOPEPTIDE AMORPHOUS CALCIUM PHOSPHATE

remineralizing agents

Eligibility Criteria

Age35 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Patients within 35-60 years of age.
  • Each patient has 4 or more exposed roots of posterior teeth having sensitivity.
  • Good oral hygiene.
  • Patients who will agree to the consent and will commit to the follow-up period.
  • Patients will follow instructions during study time.
  • Teeth that were vital.

You may not qualify if:

  • Patients with any systemic disease that may affect normal healing.
  • Patient with bad oral hygiene, high caries index and high plaque index
  • Patients participating in more than 1 dental study.
  • Active carious lesions.
  • Intrinsic and extrinsic stains.
  • Any previous filling of selected teeth.
  • Cracked and malformed teeth.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Dental Medicine ,Alazhar Univerisity

Cairo, Cairo Governorate, 11768, Egypt

Location

MeSH Terms

Conditions

Dentin Sensitivity

Interventions

Acidulated Phosphate Fluoride

Condition Hierarchy (Ancestors)

Tooth DiseasesStomatognathic Diseases

Intervention Hierarchy (Ancestors)

PhosphatesPhosphoric AcidsPhosphorus AcidsAcids, NoncarboxylicAcidsInorganic ChemicalsSodium FluorideFluoridesHydrofluoric AcidFluorine CompoundsPhosphorus CompoundsSodium CompoundsCariostatic AgentsBiomedical and Dental MaterialsManufactured MaterialsTechnology, Industry, and Agriculture

Study Officials

  • Mohamed Wakwak, A

    Alazhar Univeristy

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
ASSOCITE PROFESSOR OF OPERATIVE DENTISTRY

Study Record Dates

First Submitted

November 29, 2024

First Posted

February 20, 2025

Study Start

July 1, 2024

Primary Completion

August 1, 2025

Study Completion

December 1, 2025

Last Updated

February 20, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

privacy of patient may be may be photo of device used in the study , photo of treatment

Locations